Loading...
Small cell transformation of ROS1 fusion-positive lung cancer resistant to ROS1 inhibition
Histologic transformation from non-small cell to small cell lung cancer has been reported as a resistance mechanism to targeted therapy in EGFR-mutant and ALK fusion-positive lung cancers. Whether small cell transformation occurs in other oncogene-driven lung cancers remains unknown. Here we analyze...
Saved in:
| Published in: | NPJ Precis Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Nature Publishing Group UK
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7400592/ https://ncbi.nlm.nih.gov/pubmed/32802958 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41698-020-0127-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|